3-aryl-substituted imidazo[1,2-A]pyridines and their use

US9776997B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Alexandros Vakalopoulos · Hilden, DE
• Markus Follmann
• Ingo Hartung · Berlin, DE
• Philipp Buchgraber · Leverkusen, DE
• Alexey GROMOV · Erkrath, DE
• Niels Lindner · Wuppertal, DE
• Frank Wunder · Wuppertal, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Gorden Redlich · Bochum, DE
• Volkhart Min-Jian Li · Velbert, DE

Key dates

• Filing date: Jun 4, 2014
• Grant date: Oct 3, 2017
• Expiry date: Jun 4, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P13/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel 3-aryl-substituted imidazo[1,2-a]pyridines, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of cardiovascular disorders.